NCT01415258

Brief Summary

The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13). The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
209

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 11, 2011

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

August 10, 2011

Last Update Submit

March 12, 2026

Conditions

Solid Tumor

Keywords

cancervulnerabilityfrail

Outcome Measures

Primary Outcomes (1)

  • To assess the Vulnerable Elders Survey score (VES-13)

    A patient is identified vulnerable if the score is ≥ 3

    Within 3 months after recruitment

Secondary Outcomes (2)

  • To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert

    Within 3 months after recruitment

  • To measure the muscle strength using the grip strength test

    Within 3 months after recruitment

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study concerns elderly patients (≥70 years) with solid tumors

You may qualify if:

  • patient aged ≥ 70
  • coming for a first visit, whatever the purpose and the disease stage

You may not qualify if:

  • neglect or refusal to answer to the VES-13 test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oscar Lambret Anti-Cancer Centre

Lille, 59020, France

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Véronique SERVENT, MD

    Oscar Lambret Anti-Cancer Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2011

First Posted

August 11, 2011

Study Start

March 1, 2011

Primary Completion

August 1, 2011

Study Completion

April 1, 2012

Last Updated

March 16, 2026

Record last verified: 2026-03

Locations

FR(1)